Login / Signup

The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity.

Magnus F G GrøndahlJonatan I BaggerMalte P SuppliGerrit Van HallNicolai J W AlbrechtsenJens J HolstTina VilsbøllMikkel B ChristensenAsger B LundFilip K Krag Knop
Published in: Endocrine connections (2024)
The hormone glucagon stimulates glucose production from the liver, which may promote hyperglycaemia if glucagon levels are abnormally elevated, as is often seen in type 2 diabetes and obesity. Glucagon levels are closely linked to, and influenced by, the levels of circulating amino acids. To further investigate this link, we measured amino acid levels in individuals with and without obesity and type 2 diabetes before and during an infusion of glucagon. We found that circulating amino acid levels were higher in type 2 diabetes and obesity, and that glucagon infusion decreased amino acid levels in both individuals with and without type 2 diabetes and obesity. The study adds novel information to the link between circulating levels of glucagon and amino acids.
Keyphrases
  • type diabetes
  • amino acid
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • glycemic control
  • cardiovascular disease
  • weight gain
  • healthcare
  • low dose
  • body mass index
  • social media